Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: mental  health  study  23andme  bipolar  attention  healthcare  treatment  multivu  8150951  teenage  pregnancy  kicks  playground  mobile  phone  girls  fight  leicester  midlands  baby  birth  nhs  delivery  janeway  immunobiology  janeway  immunobiology  pdf  download  free  paul  walker  davidoff  cool  water  actor  celebrity  ocean  conservation  fragrance  cologne  consumer  multivu  49811  childrens  hospital  philadelphia  lymphoma  neuroblastoma  cancer  medication  treatment  genes  therapy  health  multivu  50776  astellas  innovation  debate  2015  dna  igenes  health  healthcare  biology  pharmaceutical  medicine  healthcare  multivu  7424051  ddn  storage  datadirect  networks  big  storage  scalable  storage  virginia  bioinformatics  institute  ebola  multivu  7429756  skincare  health  science  museum  glycobiology  cosmetics  ysl  beaute  forever  youth  liberator  serum  beauty  multivu  7709551  skincare  health  science  museum  glycobiology  cosmetics  ysl  beaute  forever  youth  liberator  serum  beauty  multivu  7709551  video  super  ilginc  evrim  hayvan  yasam  film  hayat  yasam  baslangic  baslamak  evrilmek  doga  yapay  hucre  test  deney  hastalik  euclid  cdi  hospital  clinic  diagnosis  europe  awareness  test  healthcare  multivu  71400524  jean  krutmann  tech  biology  lifespan  vichy  laboratoires  research  cancer  health  multivu  7751451 
Search // biology
Results 1-9 of 9 for ' biology ' (0 seconds)
23andMe, working in collaboration with the Milken Institute and Lundbeck, today announced that they have commenced enrollment for a first-of-its kind genetic study designed to gain understanding of the underlying biology of major depressive and bipolar disorders. This study will combine cognitive assessments with genetic data and survey responses to assess how genes influence brain processes – such as attention, decision-making and visual perception – in individuals who live with these serious mental health conditions. “We know genetics play a role in the development of depression and bipolar, however there is a long pathway from our genes to the manifestation of complex diseases like these,” said Emily Drabant Conley, PhD., Vice President of Business Development at 23andMe. “We need to look at these conditions in a more comprehensive way to advance our understanding. By studying cognitive function alongside genetics and other environmental variables on a massive scale, we hope to take a significant step forward in the study of depression and bipolar.” To view the multimedia release go to: https://www.multivu.com/players/English/8150951-23andme-genetic-study-depression-bipolar-disorders/
Categories // Miscellaneous 
Added: 2430 days ago by MultiVuVideos
Runtime: 1m0s | Views: 29831 | Comments: 1
Not yet rated
 

 

 

Teenagers filming fights on their camera phones is as old as happy slapping, but this footage from a school in Leicester is pretty shocking by anyone\'s standards. Something they don\'t prepare you for in biology class.
Categories // Miscellaneous  Family  Street 
Added: 5428 days ago by mcmentalninja
Runtime: 0m43s | Views: 12565 | Comments: 2
Not yet rated
 

 

 

The American actor has conquered Hollywood with “The Fast and the Furious” films, and has proven his love for acting and action in films including Clint Eastwood’s “Flags of Our Fathers,” “Eight Below,” “Joy Ride” and “Takers.” He is reprising his role opposite Vin Diesel in “Fast Five”. Having studied marine biology, Paul is known for his passion for the ocean, ocean conservation, diving and surfing. To view Multimedia News Release, go to http://www.multivu.com/players/English/49811-Paul-Walker-for-Davidoff-Cool-Water-Cologne/
Categories // People and Blog  Business 
Added: 4670 days ago by MultiVuVideos
Runtime: 1m1s | Views: 6237 | Comments: 3
Not yet rated
 

 

 

A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma. A phase 1 clinical trial of the drug crizotinib achieved remissions, with minimal side effects, for 10 of the children participating in a clinical study carried out by the multicenter Children’s Oncology Group (COG). The results were “an exciting proof-of-principle” for the targeted treatment, said the study leader, Yaël P. Mossé, M.D., a pediatric oncologist at The Children’s Hospital of Philadelphia. “We are entering a new era of cancer therapy, in which we use knowledge of basic biology to design very specific drugs that target cancer cells with potentially less side effects on healthy tissue,” said Mossé. “In addition, as we concentrate on targets in molecular pathways, we move away from an exclusive focus on one form of cancer to customizing treatments according to biological activity. Abnormal ALK activity occurs in subtypes of neuroblastoma and subtypes of lymphoma, so identifying ALK activity in individual patients may enable us to provide the most effective care.” To view Multimedia News Release, go to http://www.multivu.com/mnr/50776-childrens-hospital-philadelphia-lymphoma-neuroblastoma-oncology-gene-trial
Categories // People and Blog 
Added: 4333 days ago by MultiVuVideo
Runtime: 4m41s | Views: 4476 | Comments: 0
Not yet rated
 

 

 

Barrister, peer and Vice-President of the Patients Association Baroness Helena Kennedy has joined a panel of internationally recognised experts for the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain. Organised and funded by Astellas, a progressive pharmaceutical company that explores the frontiers of scientific discovery to translate new knowledge into innovative, reliable medicines, the Astellas Innovation Debates are a series of annual events that bring together some of the world’s most progressive thinkers to discuss the role of innovation in solving some of the greatest challenges of our time. To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7424051-helena-kennedy-astellas-debate/
Added: 3355 days ago by MultiVuVideos
Runtime: 2m58s | Views: 858 | Comments: 2
Not yet rated
 

 

 

Virginia Bioinformatics Institute (VBI), a world-class research institute dedicated to the study of information biology, is using DataDirect Networks (DDN) SFA® high-performance storage engine-based GRIDScaler GPFS parallel file system to perform rapid, accurate Ebola outbreak modeling for the U.S. Department of Defense’s Defense Threat Reduction Agency (DTRA). A team of 30 researchers and scientists on VBI’s Ebola rapid response team initially provided DTRA and West Africa’s Ministries of Health (MOH) with short-term forecasts on vaccine production and disease spread. To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7429756-ddn-gridscaler-vbi-ebola/
Added: 3319 days ago by MultiVuVideos
Runtime: 3m38s | Views: 835 | Comments: 2
Not yet rated
 

 

 

Announced today by VICHY Laboratoires, the VICHY EXPOSOME GRANT will promote and encourage research activity on the skin exposome. One research grant of 15 000 € will be awarded annually to a research project proposal in the field of exposome and skin. What is exposome? The human body is subjected to and responds to complex exposures throughout the lifespan, including exposures from the environment, diet, lifestyle. For this highly complex interaction, the term exposome was recently coined by Dr. Christopher Wild at the World Health Organization‘s International Agency for Research on Cancer. The exposome analysis, therefore, complements the human genome by providing a comprehensive description of individuals’ lifelong environmental exposures. Exposome research aims to look at the holistic view of the human body’s exposures, how the body responds to those exposures, and their combined effects. To view the multimedia release go to: http://www.multivu.com/players/uk/7751451-vichy-announces-exposome-grant/
Categories // Miscellaneous 
Added: 2948 days ago by MultiVuVideos
Runtime: 2m15s | Views: 658 | Comments: 0
Not yet rated
 

 

 

Announced today by VICHY Laboratoires, the VICHY EXPOSOME GRANT will promote and encourage research activity on the skin exposome. One research grant of 15 000 € will be awarded annually to a research project proposal in the field of exposome and skin. What is exposome? The human body is subjected to and responds to complex exposures throughout the lifespan, including exposures from the environment, diet, lifestyle. For this highly complex interaction, the term exposome was recently coined by Dr. Christopher Wild at the World Health Organization‘s International Agency for Research on Cancer. The exposome analysis, therefore, complements the human genome by providing a comprehensive description of individuals’ lifelong environmental exposures. Exposome research aims to look at the holistic view of the human body’s exposures, how the body responds to those exposures, and their combined effects. To view the multimedia release go to: http://www.multivu.com/players/uk/7751451-vichy-announces-exposome-grant/
Categories // Miscellaneous 
Added: 2948 days ago by MultiVuVideos
Runtime: 1m20s | Views: 659 | Comments: 0
Not yet rated
 

 

 

Breast cancer now represents one in four of all cancers in women worldwide and touches lives every day. While experiences with the disease may vary, the desire to defeat breast cancer is universal. This year, in honor of a shared vision for a world without this disease, The Estée Lauder Companies’ Breast Cancer Awareness (BCA) Campaign celebrates the power of global solidarity by encouraging people around the world to “Take Action Together to Defeat Breast Cancer.” The 2016 BCA Campaign invites women, men and families to draw inspiration from one another and unite in action on BCAcampaign.com and social media, while supporting lifesaving breast cancer research. Over the past two decades, The Estée Lauder Companies’ BCA Campaign, launched by the late Evelyn H. Lauder, co-creator of the Pink Ribbon and founder of the Breast Cancer Research Foundation® (BCRF), has been a leading voice for breast cancer awareness around the world, igniting a global movement that has helped save millions of lives and fund innovative breast cancer research. Today, The BCA Campaign is active in more than 70 countries and has raised more than $65 million to support global research, education and medical services, with more than $50 million funding 200 BCRF medical research grants worldwide over the past 22 years. These funds help accelerate critical research across wide-ranging areas such as tumor biology, heredity and ethnicity, lifestyle and prevention, treatment, survivorship and metastasis. Around the world, The BCA Campaign partners with more than 60 breast cancer organizations focused on breast cancer research, education and medical services. This year, The BCA Campaign is committed to raising $6 million in support of its mission to defeat breast cancer through education and medical research. To view the multimedia release go to: http://www.multivu.com/players/English/7935851-estee-lauder-bca-campaign-2016/
Categories // Miscellaneous 
Added: 2736 days ago by MultiVuVideos
Runtime: 0m30s | Views: 578 | Comments: 0
Not yet rated
 

 

 

Page 1 of 1  |  Go to page   



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2024 ClipMoon.com. All rights reserved.